New Ratios for the Detection and Classification of CJD in Multisequence MRI of the Brain by Marius George Linguraru A et al.
New Ratios for the Detection and Classification of CJD 
in Multisequence MRI of the Brain  
Marius George Linguraru
a,b, Nicholas Ayache
a, Miguel Ángel González 
Ballester
a,c, Eric Bardinet
d, Damien Galanaud
e,f, Stéphane Haïk
g,h,i, Baptiste 
Faucheux
g,h, Patrick Cozzone
f, Didier Dormont
d,e and Jean-Philippe Brandel
g,i 
aEPIDAURE Research Group – INRIA Sophia Antipolis, France, 
bDivision of Engineering 
and Applied Sciences, Harvard University, Cambridge MA, USA, 
cMEM-ISTB, University of 
Bern, Bern, Switzerland,  
dCNRS UPR640-LENA, Paris, France, 
eDepartment of 
Neuroradiology, La Pitié-Salpêtrière Hospital, Paris, France, 
fCRMBM UMR CNRS 6612, 
Faculty of Medicine, Marseille, France, 
gINSERM U360, La Pitié-Salpêtrière Hospital, Paris, 
France, 
hR. Escourolle Neuropathological Laboratory, La Pitié-Salpêtrière Hospital, Paris, 
France, 
iThe National Reference Cell of CJD, La Pitié-Salpêtrière Hospital, Paris, France 
mglin@deas.harvard.edu 
We present a method for the analysis of deep grey brain nuclei for accurate 
detection of human spongiform encephalopathy in multisequence MRI of the 
brain. We employ T1, T2 and FLAIR-T2 MR sequences for the detection of 
intensity deviations in the internal nuclei. The MR data are registered to a 
probabilistic atlas and normalised in intensity prior to the segmentation of 
hyperintensities using a foveal model. Anatomical data from a segmented atlas 
are employed to refine the registration and remove false positives. The results 
are robust over the patient data and in accordance to the clinical ground truth. 
Our method further allows the quantification of intensity distributions in basal 
ganglia. sCJD patient FLAIR images are classified with a more significant 
hypersignal in caudate nuclei (10/10) and putamen (6/10) than in thalami. 
Defining normalised MRI measures of the intensity relations between the 
internal grey nuclei of patients, we robustly differentiate sCJD and vCJD 
patients, as an attempt towards the automatic detection and classification of 
human spongiform encephalopathies. 
1 Introduction 
The identification of diagnosis markers is a major challenge in the clinical care of 
patients with Creutzfeldt-Jakob Disease (CJD). This disease raises a number of 
questions to neuroradiological centres, due to the limited available knowledge that 
connects it to medical imaging. Some recent studies [1,5,13] found strong 
correspondences between the diagnosis of CJD and the detection of signal 
abnormality in the deep grey matter internal nuclei in Magnetic Resonance Imaging 
(MRI) of the brain. However, the observations describing the MRI ability to help in 
the diagnosis of CJD are in an early stage. Most of the studies are concerned with 
sporadic CJD (sCJD) cases, which represent 80% of all forms of CJD. The first study cases describe hypersignals in T2-weighted images (and FLAIR-T2) with higher 
incidence in the basal ganglia in a bilateral symmetric form [1,6]. 
A great concern has been the occurrence in the United Kingdom of variant CJD 
(vCJD) in the 1990s, a form of human environmentally acquired CJD. In FLAIR and 
T2 sequences, abnormal high signals are observed in the thalamus, mainly in the 
posterior pulvinar nucleus. Unlike in sCJD cases, in vCJD cases abnormal intensities 
are higher in the pulvinar when compared to striatum [13].  
MR related image processing is an important tool in non-invasive CJD diagnosis 
[5,6]. At present time, MRI is not included as a diagnosis criterion for sCJD, which 
would be certainly useful to include, as for vCJD [13].  
Leemput [12] proposes a method for automated quantification of MR intensity 
changes in images of CJD patients. A mixture model of normal distributions 
combined with the expectation-maximisation algorithm (EM) is proposed. However, 
the method does not detect signal abnormalities in all the CJD cases, while showing 
significant amounts of false positives (FP) along the interface between grey matter 
(GM) and cerebrospinal fluid (CSF). 
Colchester, Hojjat et al. [3,7] analyse the putamen intensity gradient to separate 
CJD from controls and propose several ratios (e.g. posterior thalamus to caudate and 
most notably to frontal white matter) to differentiate vCJD from the rest. They use 
T2-weighted and Proton Density MRI for average intensities (not hyperintensities) 
and their segmentation is performed manually. 
The image blurring due to motion artefacts in the set of images of patients 
suffering of dementia makes the use of statistical detection algorithms very difficult. 
They need good contrast between GM and white matter (WM) for stochastic analysis 
according to a general atlas context. The approach we propose is based on image 
normalisation and the use of a priori anatomical knowledge in the form of an 
accurately segmented and labelled image (e.g. the Zubal Phantom [12]) for precise 
segmentation and of a probabilistic atlas for intra- and inter-patient analysis. A feature 
detection technique based on a model of the Human Visual System (HVS) is 
employed for the depiction of hypersignals. We differentiate different types of human 
prion diseases (sCJD from vCJD) based on the lesions topographical distribution.  
2 Pre-Processing and Segmentation 
The sequences used by our algorithm are: a T1-weighted acquisition for its higher 
contrast between GM and WM and higher image resolution; T2-weighted images for 
the good contrast between CSF and brain parenchyma; and a T2-weighted FLAIR 
sequence for the detection of CJD signs in the brain. We use a model of data 
normalisation and regularisation, which is required to put the images in the same 
general framework to reduce the number of parameters. A review of the different 
stages of our segmentation algorithm is shown in Figure 1.  
Data registration to an atlas has become a common technique with the introduction 
of popular statistical algorithms for image processing. A well-known probabilistic 
atlas in the scientific community is the MNI Atlas from the Montreal Neurological 
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individuals. We used a block matching-based affine transformation described in [10] 
to register the patient T1, T2 and FLAIR images to the MNI atlas. 
 
Figure 1: Flowchart of the algorithm proposed for the detection of CJD-related abnormal 
hyperintensities in multisequence MRI of the brain. 
In addition to geometric variability, MR images may also exhibit intensity 
variations. Our method performs an affine equalisation using the joint histogram of 
two images [11]: a standard image (from our database) onto which we align the 
intensity distribution of the second image.  
Our analysis is based on the abnormal MR intensities that can appear in the basal 
ganglia (including the thalamus) of CJD patients, which often show movement 
artefacts and therefore low contrast in images. The MNI atlas can provide a 
probabilistic segmentation of GM, which is not precise enough for our application. 
While avoiding direct non-rigid registration, the affine registration is approximate. 
We use instead a segmented anatomical atlas of the brain, the Zubal Phantom [12]. 
The Zubal atlas offers a precisely labelled segmentation of brain structures from 
the T1-weighted MR image of a single subject. First, the atlas must be aligned to our 
set of images; thus, we register the Zubal Phantom to the MNI template, again using 
the block-matching algorithm [10]  
Some important anatomical landmarks in the brain that are easier to identify are the 
ventricles and cortex external boundary. We segment them by morphological opening 
on patient T1 and T2 images. Ventricles will give a good approximation of the 
deformation field around the internal nuclei, whereas the cortex boundary will impose 
the global spatial constraints and stabilise the deformation field inside the brain. We 
are now in the possession of two binary maps of ventricles and brain boundaries for 
each patient: one from the Zubal Phantom and the other from the patient. Non-rigid 
registration is used to align the two images and compute deformation fields, 
employing the iconic feature-based algorithm described in [2]. 
We create a mask with the pulvinar, “anterior thalamus” (the part of thalamus with 
small probability to show abnormal signals in CJD patients), putamen and head of the 
caudate - which will be referred as internal nuclei for the rest of this paper - from the 
Zubal Phantom registered on MNI. Then we apply the above computed patient-
specific deformation fields to the mask of internal nuclei of the Zubal Phantom. The 
deformed mask is used to segment the internal nuclei on the patient image.  A foveal segmentation algorithm (HVS) [9] completes the detection of areas of 
CJD MR hypersignals in the brain. This is in essence an algorithm of adaptive 
thresholding, which uses a mathematical model of human vision. A simplified model 
for the computation of the adaptive threshold Cmin is shown in equation (1), where cmpc 
is the minimal perceivable contrast, b is constant, µN the mean value of the intensity of 
neighbourhood and µA a mean weighted value of neighbourhood and background 
(entire image).  
 
   (1) 
cmpc can be computed as a function of the image gradient. In MR images of the 
brain, the intensity values of GM, WM and CSF can be regularised by intensity 
normalisation and cmpc can be kept constant. Using an adaptive contrast measure both 
locally and globally, through the HVS foveal segmentation, our algorithm is less 
sensitive to artefacts, image quality and GM/WM contrast. 
3 Intensity Quantitative Analysis 
With the tools developed in this study, we can perform what seems to be the first 
computer-aided quantitative analysis between intensities in caudate nuclei or 
putamen, on one hand, and thalami (pulvinar nuclei and anterior thalami), on the other 
hand, for CJD patients. We will refer to it as Intensity Quantification Study (IQS).  
We use the segmented putamen, caudate nuclei, pulvinar and anterior thalami on 
the patient images to compute the mean MR intensities in nuclei. We calculate the 
absolute values   and   as in equation (2) for each patient and control, where Pul, 
Put , CN and  AT are mean intensities respectively in the pulvinar, putamen, caudate 
nuclei and anterior thalamus. M is the maximum of all   and   over all controls.  
 
   (2) 
We define a first CJD prompting ratio (CP) for the separation of CJD patients from 
healthy cases as in equation (3). CP reflects the value in each control that is closer to 
the patient data and therefore less discriminating, while in patients it highlights the 
most suspicious grey nuclei (as not all nuclei are affected in a patient and different 
types of CJD affect stronger different nuclei).  
We further define a first CJD characterisation ratio (CC) to differentiate between 
sCJD and vCJD based on the lesions topographical distribution, as in equation (3). 
HPul and HCN represent the mean hyperintense (abnormal) values (lesion specific) 
in the pulvinar and caudate nuclei. Since lesions show hyperintensities, HPul and 
HCN are used to calculate CC instead ofPul and CN . 
CP = maxcase( /, /,/ Pul AT Put AT CN AT ), CC = / HCN HPul     (3) 
4 Results  
The database comprises a total number of 23 MR image sets acquired in two major 
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5 vCJD cases (2 definite and 3 probable cases with detection of PrPres in tonsil 
biopsy); and 8 healthy controls of similar ages to the patients. The images collected in 
Paris were acquired using a 1.5 Tesla GE Signa scanner: T1 (TE=20, TR=500), T2 
(TE=92, TR=3000) and FLAIR-T2 (TE=148.5, TR=10002, TI=2200). The CJD data 
collected in Marseille were acquired using a 1.5 Tesla Siemens Magnetom Vision 
scanner: T1 (TE=15, TR=644), T2 (TE=22, TR=4000) and FLAIR (TE=110, 
TR=8000, TI=2200). Through intensity normalisation and the use of normalised ratios 
we can treat all data together for hypersignal segmentation.  
Two radiological experts annotated all patient images. Figure 2 shows detection 
results on two patients with post-mortem neuropathologically confirmed CJD. The 
main radiological characteristic of the ten sCJD patients is the presence of higher 
intensities in the caudate nuclei and putamen. Strong thalamic abnormal intensity 
distributions are present in all vCJD cases, especially in the pulvinar. No false 
positives (FP) are detected in the control images. 
Figure 2: Results on patient data – on the left an sCJD case with asymmetric lesions; on the 
right a vCJD case. We present a cross-section of each contrast-enhanced FLAIR MR data with 
abnormal hyperintensities in the internal nuclei; next to it we have the CJD detection map. 
4.1 CJD Prompting 
For the intensity quantification (IQS), we prefer using FLAIR images before intensity 
normalisation (which was used for the hypersignal segmentation) for the most 
accurate estimation of mean values in the segmented internal nuclei. This naturally 
leads to different intensity values for the Paris (M=9.48) and Marseille (M=25.63) 
databases, as a result of using different MR scanners and acquisition protocols. The 
results are consistent over the sCJD patients and conform to the clinical observations, 
where cases can be differentiated from controls judging by the   and    values 
higher than M. There is no significant difference between mean intensities in putamen 
or caudate nuclei versus pulvinar for our control data. 
We further compute the CP normalised measure for the entire database. We select 
the values in patient data that are greater than the highest value of all ratios over the 
control data (which is 1.155). All patient data provide at least one suspicious value 
higher than 1.155. All 10 sCJD cases show significant values in the caudate ratio, 
while 8/10 in the putamen ratio too. 4/5 vCJD cases present significant values in the 
pulvinar ratio, while 3/5 in the putamen and caudate nuclei, when mean intensities 
(not hyperintensities) over the entire nucleus are computed.  We box plot the value of CP into two groups: 1 - CJD cases (sporadic and variant 
together) and 2 – controls, as shown in Figure 3. For each group of data (CJD patients 
or controls), the plot shows the group median value (the bold central line), the 
minimum and maximum values (at the end of the dotted lines), the lower and upper 
quartiles (which enclose the box around the median), and the outliers (in circles). 
Performing a Welch Two Sample t-test between the two groups we get a value of p = 
6.729e
-6, which gives an excellent separation between patients and controls with ratio 
mean values of 1.266 for CJD patients and 1.092 for controls.  
4.2 CJD Characterisation 
It is important to compute mean intensities over the entire nucleus (i.e. pulvinar, 
putamen or caudate) to be able to distinguish patients from controls (who have no 
hyperintensities in the deep grey nuclei). The addressed internal nuclei do not show 
hyperintensities for all patients; the caudate appears to be the only nucleus constantly 
affected. Moreover, only parts of a nucleus may show hyperintensities and therefore 
the mean value computed over the entire nucleus does not always reflect the degree of 
abnormality in the respective patient nucleus. Therefore the need to concentrate on the 
hyperintense areas, rather than the entire nucleus. The abnormal intensities we will 
refer to are the hyperintensities found by our detection algorithm based on a foveal 
model (HVS). 
We compute the CC ratio for each patient. All 10 sCJD cases have the CC ratio 
greater than 1, while all 5 vCJD cases have the CC ratio lower than 1. These results 
prove in a quantitative form that vCJD patients present higher abnormal intensities in 
the pulvinar than putamen or caudate nuclei, whereas sCJD patients show stronger 
hyperintensities in the caudate nuclei or putamen than pulvinar. 
The box plot of the two patient subgroups is presented Figure 3. The two 
distributions are clearly different, as shown by the result of the Welch Two Sample t-
test with a p value of 5.865e
-6. The ratio mean values of the two classes are 1.190 for 
the sCJD and 0.967 for the vCJD.  
 
Figure 3: Prompting and differentiating CJD: on the left the boxplot separating CJD patients 
(sCJD and vCJD together) from controls using the CP ratio shown on the vertical axis; on the 
right the boxplot separating sCJD patients from vCJD cases using the CC ratio shown on the 
vertical axis. 
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The IQS separates on a first instance the CJD patients from healthy controls using 
the newly-defined CP ratio. Once the CJD cases isolated, we use the CC ratio to 
discriminate vCJD cases from sCJD. The IQS allows differentiating without 
ambiguity three distinctive classes: healthy controls, sCJD patients and vCJD patients. 
With a combination of HVS and IQS, we are able to prompt 15/15 prion disease cases 
with no FP amongst the controls and distinguish between sCJD and vCJD cases.  
5 Discussion and Conclusion 
We present a quantitative numerical analysis of MR intensities of pulvinar versus 
putamen and caudate nuclei in FLAIR-T2 images of CJD patients. They accurately 
quantify the clinical remarks related to the possible classification of different types of 
human spongiform encephalopathies.  
We define two new MRI-based ratios to prompt and differentiate CJD forms. All 
patients show abnormal intensities in the deep grey nuclei, which are correctly 
detected by our algorithm. All ten sCJD patients have higher mean intensities in the 
caudate nuclei and generally putamen. vCJD cases show more significant 
hyperintensities in the pulvinar than in the other deep grey nuclei, which makes them 
separable from the sCJD cases. All our experimental results are in complete 
accordance with the neurological findings in clinical practice and with the brain 
lesions profile described in each form of the disease.  
In order to decrease the number of FP prompted by our detection algorithm, we 
refined the registration of the segmented data (the Zubal Phantom) on the patient 
specific data. We use intensity normalisation for the automated segmentation of 
hyperintensities, but the quantitative analysis is performed on the original values.  
Quantifying the intensities in thalami, caudate nuclei and putamen, we show that 
there are always higher mean intensities in the caudate nuclei (10/10) and sometimes 
putamen (6/10) than the pulvinar of sCJD patients. The caudate nucleus is also of high 
intensity in the vCJD cases. This conclusion highlights the caudate nuclei as area of 
interest for the diagnosis of CJD, in complete agreement with the neuropathological 
findings. The relevance of caudate nuclei is also underlined by the decreased 
quantified mean ADC values in sCJD patients versus normal data (Diffusion Tensor 
and Diffusion Weighted images were available for some patients and controls in our 
database, but the results are preliminary).  
The algorithm allows the study of asymmetries in CJD MR hypersignals, which 
has been long questioned by neuropathologists. Using basal ganglia masks, we also 
note that hypersignals are inhomogeneous over the nuclei.  
We differentiate without ambiguity all CJD cases (sporadic and variant) from 
healthy controls and further characterise the CJD patients into two subgroups of 
human spongiform encephalopathies, sporadic and variant. More validation will be 
performed in future work, when more patient data are available. 
The reader can refer to a detailed version of the methodology in this paper in [8]. 
We presented a method for the detection of hypersignals in grey matter internal 
nuclei from multisequence MR images. The particular context of our application is 
that of human spongiform encephalopathies, prion protein diseases referred as 
Creutzfeldt-Jakob Diseases (CJD). The technique employs intensity and spatial normalisation, foveal segmentation for the detection of hyperintensities and a priori 
anatomical information for refined registration and removal of false positives. We are 
able to prompt 15/15 prion disease cases with no FP amongst the controls. Our 
method further allows the quantification of intensity distributions in basal ganglia, as 
we introduce two MRI-based ratios that discriminate between patients and normals 
and differentiate between CJD forms. The caudate nuclei are highlighted as main 
areas of diagnosis of sCJD, in agreement with the histological data. In vCJD patients, 
we find more significant hyperintensities in the pulvinar than in the other internal 
nuclei, which confirms the visually-based radiological observations related to CJD. 
Our method proves as reliable as the visual interpretation of radiologists for the 
detection of basal ganglia hypersignals. Moreover, it allows to automatically obtain 
quantitative data from MR patients with CJD, which could be used for the follow-up 
of patients and evaluation of the efficiency of therapeutic procedures. Our study 
demonstrates the value of MRI for a prospective non-invasive diagnosis of sCJD and 
the characterisation of prion diseases, as we clearly differentiate sporadic from variant 
CJD cases. This work was partially funded by the GIS-Prions project. 
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